<DOC>
	<DOCNO>NCT00913029</DOCNO>
	<brief_summary>Prospective , unmasked , randomized evaluation iStent patient primary open-angle glaucoma . Patients randomize one two group : 1 ) iStent , 2 ) medication .</brief_summary>
	<brief_title>Evaluation iStent Versus Two Ocular Hypotensive Agents Patients With Primary Open-angle Glaucoma ( POAG )</brief_title>
	<detailed_description>Two hundred patient enrol study 21 clinical site ; follow-up 1 year .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Diagnosis primary openangle glaucoma Male female least 18 year age able provide write informed consent Mean IOP ( baseline visit washout medication ) must 22 mm Hg great 38 mm Hg Likely available willing attend followup visit Angle closure glaucoma Secondary glaucoma Prior glaucoma procedure Elevated episcleral venous pressure history active thyroid orbitopathy , carotidcavernous fistula , orbital tumor , orbital congestive disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>primary open angle glaucoma ( POAG )</keyword>
	<keyword>OAG</keyword>
	<keyword>glaucoma</keyword>
</DOC>